Molecular Cell APC and Open Access: $9,350 for a Cell Press Specialty Title

Molecular Cell is hybrid, giving you two routes:

1. Subscription track (default, $0): Your paper is published on the Cell Press website behind the paywall. Readers access it through institutional subscriptions. You pay nothing.
2. Gold open access track ($9,350): Immediate free access for all readers under a Creative Commons license. You or your funder/institution pays.

The subscription route is the default for most Molecular Cell authors. The journal has strong institutional readership through Elsevier's ScienceDirect platform, and the core audience (molecular biologists at research universities) almost universally has institutional access.

The central cost problem with Molecular Cell is the same as with every Cell Press title: exclusion from Elsevier's institutional agreements.

Elsevier has transformative agreements with hundreds of institutions covering APCs for 1,800+ "core hybrid journals." Cell Press titles are not in that group. This means:

The UC system's expanded Elsevier agreement (2025) includes Cell Press, but this is exceptional. Most universities' Elsevier deals still exclude Cell Press journals. Before choosing OA at Molecular Cell, ask your library the specific question: "Does our Elsevier agreement include Cell Press?"

Cell Press uses Elsevier's waiver infrastructure:

Geographical pricing (GPOA):

Authors from lower-income countries receive discounted APCs through Elsevier's Geographical Pricing for Open Access program. The discount is calculated automatically during the payment process based on your institutional affiliation and country. Discounts range from 25% to 100%.

Elsevier's GPOA uses a proprietary tiering system that's less transparent than Springer Nature's Research4Life framework. You won't know your personalized APC until you reach the payment stage.

Financial hardship waivers:

Available on a case-by-case basis. Contact the editorial office after acceptance if you have no institutional or funder support and can't afford the APC. Success rates are not publicly reported.

No relevant society discounts:

There's no partnership between Cell Press and the major molecular biology societies (ASBMB, RNA Society, etc.) that would provide APC reductions for society members.

Molecular Cell supports CC BY and CC BY-NC-ND licenses. Plan S mandates CC BY. If your funder is a cOAlition S member, select CC BY during licensing. CC BY-NC-ND does not satisfy Plan S.

For NIH-funded researchers, the green route is available: publish via subscription (free) and deposit the accepted manuscript in PubMed Central after 12 months. This is the path most US-based molecular biologists take when institutional OA coverage isn't available.

Molecular Cell has a well-defined editorial focus that distinguishes it from broader cell biology journals:

• Gene expression and regulation: Transcription, chromatin biology, epigenetics, and gene regulatory networks. This is the journal's core territory.
• RNA biology: mRNA processing, non-coding RNA function, RNA structure, and post-transcriptional regulation.
• DNA repair and genome stability: Damage response pathways, replication mechanisms, and chromosome biology.
• Protein homeostasis: Ubiquitin-proteasome system, autophagy, protein folding, and quality control.
• Structural biology: Cryo-EM and crystallographic studies of molecular machines, particularly those involved in gene expression or genome maintenance.

The journal was launched in 1997 as Cell's molecular biology counterpart. It publishes roughly 150-180 articles per year, with an acceptance rate estimated at 7-9%. The editorial bar is mechanistic depth: Molecular Cell wants papers that explain how molecular machines work, not just what they do.

Molecular Cell is published monthly with a typical time from submission to first decision of 3-5 weeks. Revision periods can extend 3-6 months, particularly when reviewers request additional structural data or in vitro reconstitution experiments.

No submission fees, page fees, or color figure charges. But these costs catch authors off guard:

• Tax: VAT in the EU adds 15-25% on top of $9,350. Budget for the taxed amount if your institution is in Europe.
• Graphical abstract: Required by Cell Press. If you hire an illustrator, budget $200-$500.
• Structural data deposition: Molecular Cell requires deposition of structural data in the PDB, EMDB, or other repositories. Deposition is free, but preparing data files and writing deposition descriptions takes time.
• Large supplementary datasets: If your paper includes extensive genomic or proteomic data, deposition in GEO, PRIDE, or similar repositories is required. These are generally free, but extremely large datasets may incur storage costs.
• License choice errors: Selecting CC BY-NC-ND when your funder requires CC BY creates a post-publication problem. Changing the license after publication requires publisher approval and isn't straightforward.

Molecular Cell's position in the APC landscape is challenging. You're paying a premium for the Cell Press brand, but without the institutional safety net that Springer Nature provides for its competitors.

Decision framework:

1. Check your Elsevier agreement for Cell Press inclusion. Ask your library explicitly. If covered, choose OA.
2. Consider the competition. If your paper fits NAR's scope, you get free gold OA in a higher-impact journal. If EMBO Journal works, you save nearly $4,000.
3. Funder mandate? If your funder requires immediate OA and covers the cost, the $9,350 is manageable. If you're paying from a limited grant budget, $9,350 is a meaningful fraction of a typical supplies line.
4. No mandate? Publish via subscription for free. Molecular Cell's readership has institutional access, and the field values the journal name regardless of access model.
5. Want to stay in Cell Press but save money? Cell Reports at $5,790 is a strong alternative for work that's mechanistically solid but not at the top tier.

The real challenge with Molecular Cell isn't the APC. It's getting through editorial triage. The journal rejects the vast majority of submissions before review. Run a free readiness scan to evaluate your manuscript's fit before submitting. For the full Cell Press pricing picture, see our Cell APC breakdown.